Total flavonoids of Hippophae rhamnoides L. interfere with the regression of hypertrophic scar tissue blocks in a rabbit ear model

doi:10.12307/2022.940

Abstract

Abstract: BACKGROUND: Total flavonoids of Hippophae rhamnoides L. can inhibit fibrosis in the kidney, liver and myocardium. However, related studies on hypertrophic scar fibrosis are rarely reported.
OBJECTIVE: To observe the effect of total flavonoids of Hippophae rhamnoides L. on the regression of hypertrophic scar in a rabbit ear model and to explore its mechanism.
METHODS: Eight New Zealand white rabbits were selected for the study. Three round wounds with a diameter of 8 mm were made on both sides of each ear along the ventral midline, a total of 96 wounds. After 21 days of wound epithelization, all rabbits were randomly divided into five groups: 0.5, 1.0, 2.0 g/L total flavonoids of Hippophae rhamnoides L. groups, two rabbits in each group, and dimethyl sulfoxide group (drug solvent control) and blank control group, one rabbit in each group. Corresponding drugs were injected into the base of tissue once every 3 days for 4 continuous weeks. The pathological changes of hypertrophic scar tissue blocks were observed and compared by hematoxylin-eosin staining and Masson staining. The expressions of type I and III collagen mRNAs in rabbit ear scar tissue were detected by real-time PCR. Western blot was used to detect the expression of type I and III collagen, transforming growth factor β1, α-smooth muscle actin, and vascular endothelial growth factor proteins in rabbit ear scar tissue blocks.
RESULTS AND CONCLUSION: General observation: The scar tissue was softened and flattened significantly after the injection of different concentrations of total flavonoids of Hippophae rhamnoides L. In the blank control group, there were a large number of infiltrated inflammatory cells, angiogenesis and irregular arrangement of collagen fibers. Compared with the blank control group, the neat distribution and loose arrangement of fascicular collagen fibers could be observed in different concentration treatment groups, especially in the 2 g/L group. Scar elevation index and collagen fiber area density in different concentration treatment groups were significantly lower than those in the blank control group and dimethyl sulfoxide group (P < 0.05). The expression levels of type I and III collagen mRNAs in scar tissue were significantly lower in different concentration treatment groups than the blank control group (P < 0.05). The collagen transcription was most significantly downregulated in the 2 g/L treatment group. Compared with the blank control group, dimethyl sulfoxide could partly inhibit the expression of type III collagen, transforming growth factor β1, α-smooth muscle actin, and vascular endothelial growth factor. However, different concentrations of total flavonoids of Hippophae rhamnoides L. could sufficiently inhibit the expression of type I and III collagen, transforming growth factor β1, α-smooth muscle actin, and vascular endothelial growth factor in rabbit ear scar tissue in a concentration-dependent manner. To conclude, total flavonoids of Hippophae rhamnoides L. can inhibit scar hyperplasia, soften and flatten the scar tissue and lighten the color of scar tissue, which treat hypertrophic scar by reducing the expressions of transforming growth factor β1, type I and III collagen in rabbit ear scar tissue blocks, inhibiting the transformation of fibroblasts into myofibroblasts and reducing angiogenesis in scar tissue.

Key words: total flavonoids of Hippophae rhamnoides L., hypertrophic scar, collagen fiber, transforming growth factor β1, vascular endothelial growth factor

CLC Number:

Niu Zihan, Yu Yang, Ai Jiang, Bu Panpan, Li Wenbo, Suriye·Reheman, Ma Shaolin. Total flavonoids of Hippophae rhamnoides L. interfere with the regression of hypertrophic scar tissue blocks in a rabbit ear model[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(2): 258-263.

Figures/Tables 5

References

[1] LEE HJ, JANG YJ. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int J Mol Sci. 2018;19(3):711.
[2] WANG ZC, ZHAO WY, CAO Y, et al. The Roles of Inflammation in Keloid and Hypertrophic Scars. Front Immunol. 2020;11:603187.
[3] ZHANG T, WANG XF, WANG ZC, et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother. 2020; 129:110287.
[4] 张东,邬国栋. 沙棘黄酮的化学成分及药理作用研究进展[J]. 中国药房,2019,30(9):1292-1296.
[5] 周浩楠,胡娜,董琦,等. 沙棘化学成分及药理作用的研究进展[J]. 华西药学杂志,2020,35(2):211-217.
[6] 李艺文,唐志书,张珍,等. 沙棘总黄酮抗单侧输尿管梗阻大鼠肾脏纤维化作用及机制[J]. 中南药学,2021,19(5):845-850.
[7] 白跳,迟丽屹,高宇勤,等. 异鼠李素对糖尿病大鼠心肌纤维化的干预作用[J]. 新疆医科大学学报,2018,41(7):865-869.
[8] 王晖,李小静. 兔耳瘢痕模型的研究与应用进展[J]. 中华整形外科杂志,2015,31(2):158-160.
[9] 中国整形美容协会瘢痕医学分会. 瘢痕早期治疗全国专家共识(2020版)[J]. 中华烧伤杂志,2021,37(2):113-125.
[10] 韦凌霞,丁茂鹏,王志旺,等. 基于数据挖掘及网络药理学方法探讨含当归中药复方抗肝纤维化的用药规律及作用机制[J]. 中药新药与临床药理,2020,31(11):1323-1331.
[11] 盖李乐,袁丁,张长城,等. 淫羊藿总黄酮通过TGF-β1/Smad3信号通路改善自然衰老大鼠肾脏组织纤维化[J]. 天然产物研究与开发, 2021,33(3):373-379.
[12] 曹后康,高雅,黄思茂,等. 杠板归总黄酮抗大鼠肝纤维化作用的机制研究[J]. 中国药理学通报,2017,33(9):1303-1308.
[13] 焦美,钟涵宇,陈克研,等. 槲皮素通过TGF β1/Smad3信号通路改善慢性心衰大鼠心肌纤维化[J]. 解剖科学进展,2020,26(4):391-395.
[14] 高海娜,林莺,张静,等. 异鼠李素对长波紫外线照射人皮肤成纤维细胞ER/TGF-β1/Smad3信号通路的影响[J]. 国际中医中药杂志, 2020,42(10):973-977.
[15] SARI E, BAKAR B, DINCEL GC, et al. Effects of DMSO on a rabbit ear hypertrophic scar model: A controlled randomized experimental study. J Plast Reconstr Aesthet Surg. 2017;70: 509-517.
[16] YUAN FL, SUN ZL, FENG Y, et al. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids. J Cell Physiol. 2019; 234(12):21662-21669.
[17] BERMAN B, MADERAL A, RAPHAEL B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatol Surg. 2017; 43 Suppl 1:S3-S18.
[18] CHO JW, CHO SY, LEE SR, et al. Onion extract and quercetin induce matrix metalloproteinase-1 in vitro and in vivo. Int J Mol Med. 2010; 25(3):347-352.
[19] YANG JH, KIM SC, KIM KM, et al. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress. Eur J Pharmacol. 2016;783: 92-102.
[20] LIMANDJAJA GC, BELIEN JM, SCHEPER RJ, et al. Hypertrophic and keloid scars fail to progress from the CD34- /α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression. Br J Dermatol. 2020;182(4):974-986.
[21] WILGUS TA. Vascular Endothelial Growth Factor and Cutaneous Scarring. Adv Wound Care (New Rochelle). 2019;8(12):671-678.
[22] SHI J, WU Y, GUO S, et al. The efficacy of anti-VEGF antibody-modified liposomes loaded with paeonol in the prevention and treatment of hypertrophic scars. Drug Dev Ind Pharm. 2019;45(3):439-455.